Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Einsatz neuer Substanzen in der Schwangerschaft
Translated title of the contribution
:
Targeted therapy for breast cancer during pregnancy
D. Fischer
*
, C. Dittmer, N. Bündgen, K. Diedrich, M. Thill, K. Röder
*
Corresponding author for this work
Clinic of Gynecology and Obstetrics
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeted therapy for breast cancer during pregnancy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Bevacizumab
24%
Breast
17%
Breast Neoplasms
100%
Child
9%
Eye
13%
Lapatinib
31%
Oligohydramnios
31%
Pregnancy
94%
Pregnant Women
18%
Protein-Tyrosine Kinases
20%
Referral and Consultation
16%
Thalidomide
27%
Therapeutics
25%
Trastuzumab
53%